Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
910.19B
Market cap910.19B
Price-Earnings ratio
34.68
Price-Earnings ratio34.68
Dividend yield
0.65%
Dividend yield0.65%
Average volume
3.70M
Average volume3.70M
High today
$969.94
High today$969.94
Low today
$933.20
Low today$933.20
Open price
$959.78
Open price$959.78
Volume
1.63M
Volume1.63M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $963.35, giving the company a market capitalization of 910.19B. It carries a P/E multiple of 34.68 and pays a dividend yield of 64.7%.

On 2026-05-04, Eli Lilly(LLY) stock traded between a low of $933.20 and a high of $969.94. Shares are currently priced at $963.35, which is +3.2% above the low and -0.7% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.63M, compared to an average daily volume of 3.7M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

TipRanks 3h
Eli Lilly tells RBC liver case ‘not reasonably related to Foundayo’

RBC Capital notes that Eli Liily shares were down as much as 3% in pre-market trading amid reports of a single FAERS hepatic failure case reported for Foundayo,...

Barron's 3h
FDA Reports Liver Failure in Patient Taking Lilly’s Foundayo

Biotech and Pharma Street Notes FDA Reports Liver Failure in Patient Taking Lilly’s Foundayo In this article LLY SPX NVO Eli Lilly’s weight-loss pill, Foundayo,...

FDA Reports Liver Failure in Patient Taking Lilly’s Foundayo
Investor's Business Daily 4h
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect

Eli Lilly (LLY) stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure, according to a Food and Drug Administ...

Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

24/7 Wall St. 4h
This Pharma Stock Keeps Earning My Money, Here's Why

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . Lilly sits at the center of the GLP-1...

This Pharma Stock Keeps Earning My Money, Here's Why
Nasdaq 8h
Eli Lilly Just Announced Fantastic News for Shareholders

Key Points Eli Lilly is a leader in one of today’s biggest growth markets: weight loss drugs. The company recently won approval for an exciting new product....

Eli Lilly Just Announced Fantastic News for Shareholders
The Motley Fool 16h
Why Eli Lilly Stock Jumped This Week

Shares of Eli Lilly (LLY +3.30%) rose this past week after the medicine maker reported skyrocketing profits fueled by sales of its blockbuster weight loss drugs...

Why Eli Lilly Stock Jumped This Week
The Wall Street Journal 2d
The Quest to Use AI to Help Find New Drugs

Eli Lilly's supercomputer, developed with Nvidia. Lilly Eli Lilly LLY 3.07 %increase; green up pointing triangle Chief Executive Dave Ricks was on stage with N...

The Quest to Use AI to Help Find New Drugs
Simply Wall St 2d
Why Eli Lilly Is Up 9.0% After Q1 Beat And Foundayo GLP‑1 Launch - And What's Next

Eli Lilly and Company reported past first-quarter 2026 results with sales of US$19.80 billion and net income of US$7.40 billion, sharply higher than a year earl...

Why Eli Lilly Is Up 9.0% After Q1 Beat And Foundayo GLP‑1 Launch - And What's Next
Investor's Business Daily 3d
There's Another Twist In The Obesity Pills Showdown — And This One Actually Helps Lilly

Technology There's Another Twist In The Obesity Pills Showdown — And This One Actually Helps Lilly Licensing The prescription data collected for Eli Lilly's (LL...

There's Another Twist In The Obesity Pills Showdown — And This One Actually Helps Lilly
Benzinga 3d
Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules

The drugmaker reported adjusted earnings of $8.55 per share, topping analyst estimates of $6.66, while revenue rose to $19.79 billion versus expectations of $17...

Eli Lilly Jumps As Earnings Beat Meets FDA Tightening Drug Compounding Rules

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.